FOLLOW US

Endocrine Research Updates

For Medical Professionals

Lipid guidelines can inform treatment, but should be individualized.
Given so many guidelines for hyperlipidemia, the best approach is individualizing care, informed by evidence-based treatment recommendations.
Diabetes drug approvals, medication launches, and diabetes practice guidelines.
EndocrineWeb features highlights of recent government activities, new product announcements, and brief study findings to keep you informed of advances in diabetes care management.
Screening and treatment for osteoporosis is essential to avoid bone fractures.
With hip fractures rates on the rise, a concerted effort is needed to revisit regular bone screenings, and bisphosphonate treatment including education about the reality of side effects.
Patients with diabetes benefit from newly introduced apps and devices to support
Quick overview of new medical device regulations, devices, and software to inform your practice and may be of interest to trial with your patients.
Obesity in metabolic disease is due to poor mitochondrial function.
Implications for intransigent obesity may be related first to your patients’ metabolic inflexibility and only secondarily to their diet, and may offer an early warning sign of diabetes. .
Proposed new guidelines challenge current recommendations to improve management
Peer-reviewed recommendations to change the diagnosis criteria and treatment considerations for thyroid storm reflect observed patient experiences that go beyond current common sense practices.
Eating more mindfully and increasing physical activity will reduce CVD risk.
Addressing behaviors such as diet, physical activity, weight, and smoking appear to mediate development of cardiovascular disease in women who had gestational diabetes.
Harvard researchers present evidence that low TSH adversely affects fertility.
Slightly low thyroid stimulating hormone levels may offer a reason why some women struggle to get pregnant suggest Harvard researchers.
PCOS puts women at twice the risk for non-alcoholic fatty liver disease.
PCOS puts women at increased risk for steatosis and fibrosis with insulin resistance and hyperandrogenism as key factors in liver damage of these patients.
Giving breastfed babie good gut bacteria may improve their longterm health.
Boosting gut microflora may yield improvements linked to reduced dysbiosis, and potential for long-term benefit against chronic diseases.
A case for using postprandial insulin over glucose level to predict diabetes.
While promising, there is no way to know whether introducing lifestyle changes to patients who are diagnosed earlier will positively effect their outcomes.
Variability in pediatric thyroid reference ranges lessens an accurate diagnosis.
Recent research uncovers a wide variation in reference ranges for pediatric thyroid function and points to possible factors affecting thyroid hormone levels in children.
Symptoms of type 2 diabetes may prediction disease progression
Researchers followed patients who were newly diagnosed with type 2 diabetes for 18 months to classify their disease progression based on 20 baseline symptoms.
Direct intervention with an assigned appointment specialist dramatically improved retention rates and better disease outcomes among pediatric patients with type 1 Diabetes as they were transitioned to adult care.
New criteria downgrade staging for many patients with papillary thyroid cancer.
Changes to the eighth edition of the American Joint Commission on Cancer/Union for International Cancer Control 's criteria for tumor staging offer better prognosis for many patients diagnosed with papillary thyroid cancer.
Bioidentical hormones are preceived as natural but pose greater harm than HRT.
Two internationally recognized women's health experts raise concerns from use of hormone therapy from a compounding pharmacy to manage menopausal symptoms.
Senator Shaheen co-sponsors legislation to enhance diabetes research across all
Bipartisan legislation formalizing the integration of programs and activities focused on diabetes across federal agencies heads to the President for his signature.
Ultra-rapid injectable mealtime insulin receives FDA approval
A new ultra-rapid injectable synthetic insulin has been added to Novo Nordisk's antidiabetes product line-up.
Possible pathway to unrepress beta cells may lead to cure for diabetes.
Analyses of insulinomas provide pathway to pharmacologically target genes and gene families that may restore function of beta cells in individuals with type 1 and type 2 diabetes.
The lower the LDL the better with a combination of a statin and PSK9-inhibitor.
A secondary analysis of the Fourier study findings indicates that patients with the lowest LDL had best cardiovascular outcomes.
SHOW MAIN MENU
SHOW SUB MENU